[1]Fu XR,Liu G,Halim A,et al. Mesenchymal stem cell migration and tissue repair[J]. Cells,2019,8:784. doi: 10.3390/cells8080784. [2]Liu M,Chen J,Huang H,et al. Lkb1 is an important regulator of Treg differentiation and proliferation of amniotic mesenchymal stem cells[J]. Biochem Biophys Res Commun,2020,521:434-440. [3]Gao SY,Chen T,Hao Y,et al. Exosomal miR-135a derived from human amnion mesenchymal stem cells promotes cutaneous wound healing in rats and fibroblast migration by directly inhibiting LATS2 expression[J]. Stem Cell Res Ther, 2020,11:56. doi: 10.1186/s13287-020-1570-9. [4]Savelli S,Trombi L, D'Alessandro D,et al. Pooled human serum: a new culture supplement for bioreactor-based cell therapies. Preliminary results[J]. Cytotherapy,2018,20:556-563. [5]Koellensperger E,Bollinger N,Dexheimer V,et al. Choosing the right type of serum for different applications of human adipose tissue-derived stem cells: influence on proliferation and differentiation abilities[J]. Cytotherapy,2014,16:789-799. [6]Mainzer C, Barrichello C,Debret R,et al. Insulin-transferrin-selenium as an alternative to foetal serum for epidermal equivalents[J]. Int J Cosmet Sci,2014,36:427-435. [7]庞希宁,刘晓玉,霍双枝,等. 一种人羊膜间充质干细胞无血清培养基及其培养方法:中国. 专利号:ZL 2010 1 0252201.2[P]. 2012-10-10. [8]Tuca AC,Ertl J,Hingerl K,et al. Comparison of matrigel and matriderm as a carrier for human amnion-derived mesenchymal stem cells in wound healing[J].Placenta,2016,48:99-103. [9]Zisa D, Shabbir A,Suzuki G,et al. Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair[J]. Biochem Biophys Res Commun,2009,390:834-838. [10]Myers TJ,Yan Y,Granero-Molto F,et al. Systemically delivered insulin-like growth factor-I enhances mesenchymal stem cell-dependent fracture healing[J]. Growth Factors, 2012,30:230-241. |